Summary
Endosomal sorting complexes required for transport (ESCRTs) are essential for ubiquitin-dependent degradation of mitogenic receptors, a process often compromised in cancer pathologies. Sorting of ubiquinated receptors via ESCRTs is controlled by the tumor suppressor phosphatase HD-PTP. The specific interaction between HD-PTP and the ESCRT-I subunit UBAP1 is critical for degradation of growth factor receptors and integrins. Here, we present the structural characterization by X-ray crystallography and double electron-electron resonance spectroscopy of the coiled-coil domain of HD-PTP and its complex with UBAP1. The coiled-coil domain adopts an unexpected open and rigid conformation that contrasts with the closed and flexible coiled-coil domain of the related ESCRT regulator Alix. The HD-PTP:UBAP1 structure identifies the molecular determinants of the interaction and provides a molecular basis for the specific functional cooperation between HD-PTP and UBAP1. Our findings provide insights into the molecular mechanisms of regulation of ESCRT pathways that could be relevant to anticancer therapies.
Keywords: endosomal ESCRTs regulation, tumor suppressor phosphatase, ubiquitin-dependent trafficking, mitogenic signaling downregulation, coiled-coil structure
Graphical Abstract
Highlights
-
•
Crystal structure of the coiled-coil domain of HD-PTP phosphatase with UBAP1
-
•
The open and rigid architecture of HD-PTP is essential for functional recognition
-
•
Conformation and structural determinants define selectivity in Bro1 proteins
Gahloth, Levy et al. present crystal structures of the coiled-coil domain of the HD-PTP phosphatase, a regulator of ESCRT-dependent sorting, and its complex with the ESCRT-I subunit UBAP1. The structure reveals an open architecture critical for specific interactions and provides insights into how HD-PTP regulates mitogenic receptor sorting.
Introduction
Ubiquitination, endocytosis, and degradation of cell-surface receptors constitute a major mechanism of regulation of signal transduction by downregulating receptor availability for interaction with extracellular ligands. Receptor ubiquitination or degradation are often compromised in cancer pathologies, resulting in hyperactivation of signaling pathways promoting cell transformation and tumorigenesis. HD-PTP (His domain protein tyrosine phosphatase; PTPN23) is a non-receptor tumor suppressor phosphatase (Kok et al., 1997, Toyooka et al., 2000) that regulates several ubiquitin-dependent endosomal trafficking processes such as downregulation of EGFR and PDGFRβ signaling (Doyotte et al., 2008, Ma et al., 2015), recycling of Src (Chen et al., 2012, Lin et al., 2011), and degradation of α5β1 integrin (Kharitidi et al., 2015). Consequently, loss of HD-PTP promotes cell proliferation, cell migration, and invasion (Chen et al., 2012, Kharitidi et al., 2015, Lin et al., 2011, Ma et al., 2015, Mariotti et al., 2009). It has been recently reported that HD-PTP haploinsufficiency predisposes mice to tumorigenesis, while hemizygous HD-PTP deletions are observed in many human cancers (Manteghi et al., 2016).
HD-PTP drives the degradation of mitogenic receptors by coordinating their sorting into the multivesicular body (MVB) via specific recruitment of different endosomal sorting complexes required for transport (ESCRTs) (Ali et al., 2013, Stefani et al., 2011). ESCRTs (named ESCRT-0, -I, -II, and -III) are multimeric protein complexes that drive membrane remodeling and scission in a number of important cellular events, including cytokinesis, autophagy, membrane repair, and virus budding (Hurley, 2015). Pathway selectivity is defined by different subsets of ESCRTs and specialized adaptor Bro1 proteins: Bro1 in yeast, HD-PTP and Alix in animals (Bissig and Gruenberg, 2014, Ichioka et al., 2007, Kim et al., 2005). However, the mechanisms by which Bro1 proteins regulate the different ESCRT pathways remain poorly understood. For example, Alix is a general ESCRT-III regulator that supports multiple ESCRT-dependent processes (Bissig and Gruenberg, 2014, Carlton and Martin-Serrano, 2007, Morita et al., 2007, Schmidt et al., 2004, Sun et al., 2015, von Schwedler et al., 2003). In contrast, HD-PTP function is largely restricted to the early endosome (Doyotte et al., 2008, Parkinson et al., 2015) where it acts in close cooperation with ESCRT-0 (Ali et al., 2013) and UBAP1 (ESCRT-I) to downregulate multiple ubiquitinated cargoes (Agromayor et al., 2012, Kharitidi et al., 2015). UBAP1 is an ubiquitin-binding ESCRT-I subunit that acts exclusively in MVB sorting (Stefani et al., 2011, Wunderley et al., 2014) and, like for HD-PTP (Cheng et al., 1998, Toyooka et al., 2000), haploinsufficiency of UBAP1 is linked to nasopharyngeal carcinoma (Qian et al., 2001). UBAP1 is also a risk factor for familial frontotemporal lobar degeneration (Rollinson et al., 2009).
HD-PTP has a multidomain organization that allows coordinated binding to several ESCRTs (Figure 1). Knowledge of the three-dimensional architecture of HD-PTP and its mode of binding to the different ESCRTs is critical for understanding how these functional interactions are regulated. To date, structural information on HD-PTP is only available for its N-terminal Bro1 domain (Lee et al., 2016, Sette et al., 2011), which binds ESCRT-0 and ESCRT-III (Ali et al., 2013, Doyotte et al., 2008, Toyooka et al., 2000). Structures for the coiled-coil (CC) domains of other Bro1 proteins, Alix and yeast Bro1, have been reported (Fisher et al., 2007, Lee et al., 2007, Pashkova et al., 2013) and they show a V-shaped conformation, with two arms connected by a flexible hinge region (Figure 1). However, the CC domain of HD-PTP has very low homology (17%–19%) to those of Alix or Bro1, suggesting that significant structural disparity may exist. The CC domain of HD-PTP is solely responsible for the interaction with UBAP1, and residue F678 in this domain is essential for binding (Stefani et al., 2011). This Phe residue is part of a FYX2L motif (Figure 1) conserved in all Bro1 proteins (Kimura et al., 2015). In Alix, the FYX2L motif is located on the second arm of the CC domain and mediates binding to viral Gag proteins (Fisher et al., 2007, Lee et al., 2007, Zhai et al., 2008). Paradoxically, the presence of the FYX2L motif in Alix is not sufficient for binding to UBAP1 (Stefani et al., 2011), indicating that other structural determinants may be important to define selectivity.
To address this paradox and to provide new insight into the regulation of ESCRT function by HD-PTP, we have determined the crystal structures of the CC domain of HD-PTP (HD-PTPCC) alone and in complex with UBAP1. The structures show an unexpected open conformation of the CC domain, strikingly different from the V domains of Alix and yeast Bro1 (Fisher et al., 2007, Lee et al., 2007, Pashkova et al., 2013). We propose that this open conformation is critical to explain the selective binding of UBAP1 to HD-PTPCC but not to Alix. The HD-PTPCC binding interface with UBAP1 was also analyzed by nuclear magnetic resonance (NMR), paramagnetic relaxation enhancement (PRE), and surface plasmon resonance (SPR), and validated through site-directed mutagenesis and functional cell-based assays, thus establishing the structural basis for the functional cooperation between HD-PTP and UBAP1.
Results
HD-PTPCC Adopts an Open and Extended Conformation
The crystallographic structure of HD-PTPCC (apo-HD-PTPCC), determined at 2.5 Å resolution (Table 1), shows an elongated architecture with seven α helices (H1–H7) whose main feature is a central helix of 105 residues (H7) extending the whole length of the molecule (Figure 1B). The overall shape resembles that of an ice hockey stick, in which H1, H6, and the N-terminal region of H7 form the blade, and H2–H5 and the rest of H7 form the shaft (Figure 1B). The maximal dimension of HD-PTPCC is approximately 155 Å from end to end. Analysis of the structure using SOCKET (Walshaw and Woolfson, 2001) identified two canonical coiled-coil motifs: one antiparallel two-stranded coil involving helices H6 and H7 in the blade and an extensive antiparallel, tightly packed three-stranded coil involving helices H3, H4, and H7 in the shaft (Figure 1C). The topology of HD-PTPCC is such that the polypeptide chain crosses three times over the length of the protein (Figure 1D).
Table 1.
apo-HD-PTPCC | HD-PTPCC–UBAP1C | |
---|---|---|
Data Collection | ||
Space group | P21 | P21 21 21 |
Cell dimensions | ||
a, b, c (Å) | 53.5, 47.7, 172.7 | 48.9, 93.3, 102.2 |
α, β, γ (°) | 90.0, 96.0, 90.0 | 90.0, 90.0, 90.0 |
Molecules per asymmetric unit | 2 | 1 |
Resolution (Å) | 2.54 (2.63–2.54)a | 2.55 (2.64–2.55) |
Rmerge | 0.1 (0.8) | 0.1 (0.8) |
I/σI | 19.3 (3.8) | 13.6 (2.5) |
Completeness (%) | 98 (100) | 100 (100) |
Redundancy | 13.5 (13.8) | 6.3 (6.6) |
Refinement | ||
Resolution (Å) | 2.54 | 2.55 |
No. of reflections | 28,609 | 15,835 |
Rwork/Rfree | 21.7/27.8 | 20.9/25.4 |
No. of atoms | 5,156 | 2,725 |
Protein | 4,991 | 2,639 |
Peptide | NA | 73 |
Water | 80 | 31 |
B factors | ||
Protein | 49.1 | 73.6 |
Peptide | NA | 89.7 |
Water | 45.6 | 56.5 |
Root-mean-square deviations | ||
Bond lengths (Å) | 0.009 | 0.003 |
Bond angles (°) | 1.0 | 0.5 |
Each structure was determined from one crystal.
Values in parentheses are for the highest-resolution shell.
The extended shape of HD-PTPCC differs markedly from the V domains of Alix (AlixV) and yeast Bro1 (Bro1V) (Figures 1E and 1F) (Fisher et al., 2007, Lee et al., 2007, Pashkova et al., 2013). These V domains are built from two arms joined by three unstructured loops, forming a flexible hinge (Figures 1E and 1F). By contrast, in HD-PTPCC, helix H7 forms a continuous backbone (Figures 1B and 1D) that confers rigidity to the molecule.
HD-PTPCC Shows Limited Local Conformational Flexibility but No Large Structural Rearrangements
Conformational flexibility between the two arms of AlixV and Bro1V has been reported (Pashkova et al., 2013, Pires et al., 2009). We investigated the potential flexibility of HD-PTPCC using double electron-electron resonance (DEER) spectroscopy (Figure 2). This technique allows the measurement of dipolar coupling interactions between methanethiosulfonate spin labels (MTSL), covalently attached to cysteines (Figure S1). This was used here to estimate average distances between the labels (Figure 2). Comparison of these distances with those obtained from labels modeled on the HD-PTPCC crystal structure provided information on the conformational dynamics of HD-PTPCC. We conducted DEER experiments on wild-type (WT) HD-PTPCC triply labeled at C425, C628, and C697, the three cysteines present in the CC domain, and on doubly labeled mutants where each cysteine in turn had been changed to serine (Figure 2).
Significantly, the C425S mutant, doubly labeled at C628-C697 (Figure 2Ai), gave no resolved dipolar coupling, indicating that the spin labels must be separated by more than 7 nm (the maximal mean distance observable in a 6 μs window) (Figure S1). This is consistent with the extended conformation observed in the HD-PTPCC crystal structure, where the distance between labels on C628 and C697 is 9.9 nm (Figure 2C). Likewise, the interspin distance between C425 and C697 was estimated to be 6.3 nm (Figures 2Aii and 2Aiii), which matches very well with the 6.0 nm on the crystal structure (Figure 2C).
However, the interspin distance between C628 and C425 estimated at 4.2 nm (Figures 2Aii and 2Aiv) differs from the distance of 5.4 nm on the crystal structure (Figure 2C), suggesting some local conformational flexibility around C425. This residue is located in helix H2, which is connected by two flanking loops to helices H1 and H3 (Figure 1). These loops are poorly defined in the electron density maps, indicating backbone flexibility in that region. Molecular dynamics simulations around helix H2 also showed that this helix could easily adopt alternative orientations compatible with the DEER results, without requiring large overall conformational changes (Figures 2D and S2).
To confirm the above analyses, an additional Cys residue was engineered at position 521 in H4 and residues C425 and C697 were changed to Ser. In this case, the mean interspin distance between C628 and C521 (4.9 nm, Figure 2Av) was in good agreement with the distance on the crystal structure (5.4 nm, Figure 2E). The DEER analysis is therefore consistent with an overall rigid conformation for HD-PTPCC that can accommodate local flexibility without global rearrangements, ruling out a potential mechanism of regulation by large-scale flexibility of the CC domain.
Identification of the Minimal UBAP1 Binding Region to HD-PTP
Specific interaction with UBAP1 is central to the function of HD-PTP (Stefani et al., 2011), and their cooperation is essential to regulate integrin signaling and cell migration (Kharitidi et al., 2015). Therefore, we aimed to define this interaction at the molecular level. We previously identified the central region of UBAP1 (122–309) as binding to the CC domain of HD-PTP in a yeast two-hybrid (Y2H) screen (Stefani et al., 2011). We now have confirmed the interaction by co-immunoprecipitation of in vitro translated full-length UBAP1 with bacterially expressed HD-PTPCC (Figure S3). In addition, we have also shown the interaction between UBAP1 and HD-PTPCC in cells. For these experiments, a chimera of FKBP12 fused to HD-PTPBro1-CC (FKBP-HD-PTPBro1-CC) was co-expressed with a chimera of FRB (FKBP12-rapamycin binding) fused to a mitochondrial targeting sequence (mito-FRB). Treatment of cells with rapamycin caused the efficient relocalization of HD- PTPBro1-CC to mitochondria. Under these conditions, UBAP1-GFP, but not GFP, also relocated to mitochondria (Figure 3A).
Further truncations of UBAP1 (122–309) identified residues 260–269 as the minimal region for effective binding to HD-PTP (Figure 3B). This region contains an FPXL motif that resembles the YPXnL motif conserved within viral Gag late domains and other substrate proteins that bind to the V domain of Bro1 proteins (Kimura et al., 2015, Lee et al., 2007, Zhai et al., 2008, Zhai et al., 2011). The F268S mutation in this motif abolished binding to HD-PTP, while the P269A or L271A mutations had no obvious effect on binding in the Y2H assays (Figures 3A and 3B). This suggests that UBAP1 F268 forms a critical interaction with HD-PTP.
To further characterize this interaction, immobilized HD-PTPCC, HD-PTPBro1-CC, and HD-PTPBro1 were tested in biosensor binding experiments (SPR) using a UBAP1 peptide containing residues 261–280 (UBAP1C) as the analyte. Affinities of UBAP1C to HD-PTPCC and HD-PTPBro1-CC were similar, with dissociation constants Kd of 66.3 μM and 31.9 μM, respectively (Figures 3C and 3D). No binding was observed to HD-PTPBro1 (Figure 3D), thus confirming that the main UBAP1-binding region is within the CC domain, and that the conformation of the CC domain is functionally competent, both on its own and in the presence of the Bro1 domain.
Mapping the Molecular Interface between HD-PTPCC and UBAP1C
In order to define the molecular interactions, we determined the crystal structure of HD-PTPCC in complex with UBAP1C at 2.5 Å resolution (Table 1). UBAP1C adopts a rather extended conformation and binds to the shaft, near the core of the three-strand coiled coil, between H4 and H7 (Figure 4A and Figure 1C). Only residues 262–271 from UBAP1C were clearly identified in the electron density maps (Movie S1) and the side chains of I263, L266, F268, P269, and L271 are in direct contact with HD-PTPCC (Figure 4). Residues 272–280 were disordered and not visible, probably because of weaker affinity. Interactions between UBAP1C and HD-PTPCC are mainly hydrophobic, with hydrogen bonds only present between K671 on HD-PTPCC and the main chain of I263, K264, and L266 on UBAP1C (Figure 4B).
We confirmed the molecular interface between HD-PTPCC-UBAP1C using NMR by comparing the 1H 13C-heteronuclear single quantum coherence (HSQC) spectra of UBAP1C in the absence and presence of HD-PTPCC. Significant peak broadening was only observed for residues 261–271 in the presence of HD-PTPCC (Figures 5A, 5B, and S4), consistent with the interactions observed in the crystal structure, and with the minimal UBAP1 binding region identified by Y2H (Figure 3B).
The binding interface in HD-PTPCC is defined by three hydrophobic pockets (A–C in Figure 4) and the conserved FYX2L motif plays a critical role in the interaction. The aryl ring of HD-PTPCC F678 forms a wall that divides pockets B and C and contributes to multiple hydrophobic interactions with UBAP1C (Figure 4). Pocket A is large and shallow and accommodates UBAP1C residues I263 and L266. This pocket is lined by T511, L515, A518 (H4 helix) and A664, L668, K671 (H7 central helix). Pocket B is deep and narrow and accommodates UBAP1C F268 and P269. This pocket includes A508, T511 (H4), L445 (H3), and G675, F678 and Y679 (H7), forming extensive contacts with the aryl ring of F268. Pocket C accommodates L271 and includes V504 (H4) and L682 (H7). This pocket is closed off by a high rim provided by the side chains of K500, Y501 (H4), and K685 (H7) (Figure 4B).
The tight fit of F268 in the B pocket explains the key role of this residue for binding to HD-PTP, as shown by Y2H (Figure 3). Conversely, UBAP1C P269 and L271 show fewer contacts with HD-PTPCC: V504 and F678 near pocket B, and V504 and L682 in pocket C, respectively (Figure 4). The minor contribution of these two residues to the binding interface explains the weaker phenotype observed for the single mutations P269A and L271A (Figure 3), particularly in the presence of F268, which is the main anchor into the binding site. Hydrogen bonds are only present between the side chain of HD-PTPCC K671 in pocket A and the main chain of I263, K264, and L266 in UBAP1C (Figure 4B).
Pocket A is partially occluded in the structure of apo-HD-PTPCC (Figure 4E) by the side chains of K671, D667, and E514. Binding of UBAP1C thus requires re-arrangement of these three side chains (Figure 4F). In the apo-HD-PTPCC structure, D667 and K671 form a salt bridge, and the carboxyl group of E514 is about 6.4–7 Å to D667 and K671 (Figure 4F). Upon UBAP1C binding, E514, D667, and K671 side chains are displaced breaking the K671-D667 salt bridge and opening the A pocket. K671-Nζ then forms hydrogen bonds with the C=O groups of I263, K264, and L266 in UBAP1C (Figure 4B).
The orientation of UBAP1C in the HD-PTPCC binding site was validated in PRE experiments with MTSL labels at C425 and C628. Dipolar interaction with the electron spin label causes an additional component of the transverse relaxation of the NMR signal, which has strong distance dependence with maximal effect below 40 Å. The paramagnetic enhancement in this case is dominated by the spin label attached to C425, which is closer to the UBAP1C binding site. Consistent with this, NMR resonances from the N-terminal end of the UBAP1C showed enhancement of their relaxation properties and therefore loss of peak intensity in the presence of the MTSL label (oxidized form), whereas those from the region beyond L271 (>40 Å from the label) did not (Figure 5C), thus confirming the orientation of UBAP1C at the binding site.
Structural Basis for the Specific Functional Interaction of UBAP1 with HD-PTP
All Bro1 proteins contain a conserved FYX2L motif essential for binding to their substrate proteins, which contain a reciprocally conserved YPXnL motif (Kimura et al., 2015). Several structures of Alix in complex with retroviral Gag late-domain peptides (Fisher et al., 2007, Lee et al., 2007) (Figure 6) have shown that these conserved motifs interact with each other, thus confirming their functional importance. The FY pair in the FYX2L motif in Alix stacks against Y in the Gag peptide YPXnL motif, thereby serving as the main anchoring point for their interaction (Fisher et al., 2007, Lee et al., 2007). Similar binding motifs are found in HD-PTP (FYADL) and UBAP1 (FPTL), yet the binding of UBAP1 to HD-PTP is surprisingly highly selective (Stefani et al., 2011). In our HD-PTPCC-UBAP1C structure, the FY pair (F678, Y679) in HD-PTP forms stacking interactions with F268 in the FPXL motif of UBAP1C (Figure 4). The critical importance of these residues for binding was confirmed by SPR, where both the HD-PTP F678D and UBAP1 F268S mutations abolished binding (Figure 7A).
Despite similarities in the molecular recognition motifs, important differences are apparent when comparing the structures of HD-PTPCC-UBAP1C and AlixBro1-V-Gag peptide complexes. First, the binding site of UBAP1C is displaced with respect to that of the Gag peptides (Figure 6A): UBAP1C occupies pocket A in HD-PTPCC, which is poorly conserved in Alix and does not participate in Gag peptide binding (Figures 6 and S5). This displacement is possible because the architecture of HD-PTPCC offers an open, extended interface suitable to accommodate UBAP1C. In contrast, in all the complexes of AlixBro1-V with Gag peptides, both arms of the V domain form an apex that makes pocket A inaccessible, thus preventing binding due to steric hindrance (Figure 6). Second, in Alix, there is a hydrophobic binding groove that accommodates the Gag peptides and extends beyond pocket C. In HD-PTPCC, the side chains of K500, Y501, and K685 form a high rim at the edge of this pocket (Figures 4 and 6), and the three-stranded coiled coil results in tight packing between H4 and H7, leaving no room for a groove. These structural features also explain why UBAP1C is displaced toward pocket A with respect to the position of the Gag peptides on Alix (Figure 6).
We believe that the differences in the architecture and binding interface features observed between Alix and HD-PTP are critical in determining ligand-binding selectivity. We confirmed this by showing that in solution, AlixV does not bind to the UBAP1C peptide, and that a Gag peptide (SIV-GAG) does not bind to HD-PTPCC (Figure 7B), mirroring the lack of binding of full-length UABP1 to AlixBro1-V (Stefani et al., 2011). The conserved FYX2L motif is therefore necessary for binding but insufficient to determine specific selectivity between Bro1 proteins and their biological partners. Instead, both the overall architecture and local structural determinants appear to be key in defining molecular recognition and binding specificity.
Functional Validation of HD-PTP-UBAP1 Interactions
The HD-PTPCC-UBAP1C interface was validated by RNAi rescue experiments using HD-PTPBro1-CC and mutations at the binding site. In normal cells, EGFR that has been activated by EGF passes through the endosomal pathway and is degraded within lysosomes. In contrast, cells depleted of HD-PTP are characterized by the accumulation of ligand-activated EGFR in highly clustered early endosomes that label strongly for protein-ubiquitin conjugates (Doyotte et al., 2008). We have previously shown that reintroduction of HD-PTPBro1-CC is sufficient to rescue these trafficking defects and represents the minimal functional region of HD-PTP (Doyotte et al., 2008). HeLa cells depleted of HD-PTP and pulsed for 3 hr with EGF, showed intense ubiquitin labeling on cytoplasmic clusters (Figure 7C), which co-labeled with the endosomal marker EEA1 as previously reported (Doyotte et al., 2008) (data not shown). As expected, transfection of these cells with WT HD-PTPBro1-CC restored a WT phenotype, in which ubiquitinated proteins were evenly distributed throughout the cell (Figure 7C).
In contrast, the HD-PTPBro1-CC F678D mutant was unable to rescue depletion of HD-PTP, with both transfected and untransfected cells displaying strong ubiquitin labeling on cytoplasmic inclusions (Figure 7C). The HD-PTPBro1-CC K671A mutant failed to completely rescue a WT phenotype, but showed milder defects than F678D (Figure 7D). Although K671 forms hydrogen bond interactions with UBAP1C (Figures 4 and 6), its overall contribution to binding affinity is clearly less critical when compared with the contribution of the extensive hydrophobic interactions of F678. These data extend our previous findings (Stefani et al., 2011), confirm the functional significance of the interface observed in the crystal structure, and, importantly, demonstrate that binding of HD-PTP to UBAP1 is essential for correct sorting of activated EGFR, since Alix does not function in this ESCRT pathway.
Discussion
The close functional cooperation between HD-PTP and UBAP1 is physiologically crucial. Disruption of this cooperation by ablation or genetic defects leads to cancer, altered cell migration, and neurological pathologies (Cheng et al., 1998, Kharitidi et al., 2015, Qian et al., 2001, Rollinson et al., 2009). Our findings explain the structural basis for the interaction between HD-PTP and UBAP1 and reveal why UBAP1 binding is selective to HD-PTP despite conservation of the FYX2L binding motif across other Bro1 proteins. In addition, the remarkably different architecture of the HD-PTP CC domain compared with other Bro1 proteins provides further insights into the assembly of specialized ESCRTs at the endosome that drive downregulation of cell-surface receptors.
Our data show that HD-PTPCC adopts an open and extended architecture, where the CC domain maintains a rigid conformation by virtue of the long central α helix. This structure contrasts with the V-shaped CC domains of Alix and yeast Bro1 (Fisher et al., 2007, Lee et al., 2007, Pashkova et al., 2013), and is consistent with the low homology found between HD-PTPCC and these V domains.
We revealed the structural determinants for specific interaction between HD-PTP and UBAP1 by X-ray crystallography, NMR, and mutagenesis. Our results confirm that the conserved HD-PTP residue F678 in the FYX2L motif is essential for binding to UBAP1. Furthermore, key hydrophobic interactions between UBAP1 residues F268, P269, and L271 (in the FPXL motif) and HD-PTP residues F678, Y679, and L682 (in the FYX2L motif) form the core of the binding interface. We demonstrated the critical importance of F268 and F678 residues by mutagenesis, binding analysis, and functional cellular assays.
Our findings match the reported roles of Alix F676, yeast Bro1 F687, and Rim20 F623 in binding to Gag late domains, Rfu1, and Rim101, respectively (Fisher et al., 2007, Kimura et al., 2015, Lee et al., 2007). Paradoxically, conservation of the FYX2L motif in Bro1 proteins and that of the YPXnL motif in their biological targets does not result in promiscuous interactions (Kimura et al., 2015, Stefani et al., 2011). Our studies bring new insight into understanding this paradox. Significant differences in the sequence, local structural features, and hydrophobicity of the UBAP1C binding site in HD-PTP, compared with that of the Gag peptide site in Alix, are critical to determine specificity. Furthermore, the open architecture of HD-PTPCC is essential to enable binding of UBAP1C to pocket A, which is inaccessible in the V-shaped structure of Alix observed in the complexes with Gag peptides. Thus, the conformational differences may provide additional molecular determinants for the binding selectivity that we observe.
AlixV has been reported to be flexible in solution and therefore able to adopt a more open conformation (Pashkova et al., 2013, Pires et al., 2009). However, we found no evidence that Alix binds the UBAP1C peptide in our binding studies in solution, or of binding to the full-length UBAP1 by Y2H (Stefani et al., 2011).
We hypothesize that differences in the overall architecture of Bro1 proteins, and in the local features at the binding site, combine to elicit exquisite functional selectivity for ESCRT pathway regulation. This is certainly the case for HD-PTP and Alix. Whether these principles apply to other Bro1 proteins and their targets will require further high-resolution analyses of their complexes.
We found that there is no evidence for large-scale flexibility of HD-PTPCC, as has been suggested for the V domains of Alix (Fisher et al., 2007, Pires et al., 2009) and yeast Bro1 (Pashkova et al., 2013). In addition, the open conformation exhibited by HD-PTPCC most likely extends to the entire Bro1-CC region, since the UBAP1C peptide binds equally well to HD-PTPCC and HD-PTPBro1-CC. Indeed, HD-PTPBro1-CC is functionally competent as demonstrated by its binding to UBAP1 in cells and its ability to rescue defects in EGFR sorting caused by RNAi-mediated depletion of endogenous HD-PTP. Altogether, these new findings point to fundamental differences in how HD-PTP and Alix are regulated and how they control ESCRT function to define pathway diversity at different sub-cellular locations.
Experimental Procedures
Cloning, Protein Expression, and Purification
Constructs for HD-PTPBro1 (1–361), HD-PTPCC (363–712), and AlixV (358–702) were subcloned into a pNIC28a-Bsa4 vector (gift from Opher Gileadi; Addgene no. 26103). HD-PTPBro1-CC (1–714) was cloned into a pET28a vector with restriction sites Nde1 and Xho1. Point mutants were generated by quick-change primers using Phusion DNA polymerase (New England Biolabs). Constructs were expressed in BL21(DE3) Escherichia coli using 0.1 mM isopropyl β-D-1 thiogalactopyranoside induction overnight at 20°C. Cells were lysed in 20 mM HEPES (pH 7.0), 500 mM NaCl, 10 mM imidazole, 2 mM phenylmethylsulfonyl fluoride by sonication, and the supernatant was clarified by centrifugation at 12,400 × g for 1 hr. Proteins were purified by affinity chromatography using nickel-beads (QIAGEN) pre-equilibrated in binding buffer (20 mM HEPES, 500 mM NaCl, 10 mM imidazole [pH 7.4]) followed by anion-exchange chromatography with a Mono Q 5/50 GL column (GE Healthcare) in 20 mM HEPES (pH 7.4), 2 mM EDTA, 2 mM DTT, and super elongation complex (SEC) using a Superdex200 column (GE Healthcare) in the same buffer. Incorporation of L-selenomethionine was achieved by growing a culture in M9 minimal medium (Molecular Dimensions) supplemented with essential amino acids (100 mg/L each) and selenomethionine (80 mg/L).
Crystallization and Structure Determination
For crystallization, the His6 tag of HD-PTPCC was removed by cleavage with tobacco etch virus protease followed by nickel-affinity chromatography and further purification as above. apo-HD-PTPCC (11 mg/mL) was crystallized in 0.1 M Bis-Tris (pH 6.0), 0.1–0.2 M Na-formate, and 13%–15% PEG3350 at 21°C. Crystals of the HD-PTPCC-UBAP1C complex were obtained by mixing HD-PTPCC (1 mg/mL) with 1 mM UBAP1 peptide and concentrated to 11 mg/mL from a reservoir solution of 0.2 M KSCN, 20% PEG3350. All crystals were cryo-protected in perfluoropolyether cryo oil (Hampton Research) prior to freezing in liquid nitrogen. Data were collected at I02 and I03 beamlines in Diamond Light Source (UK) and processed with XDS (Kabsch, 2010). The structure of apo-HD-PTPCC was determined by selenium single-wavelength anomalous diffraction (Se-SAD) using PHENIX AutoSol, and the initial model built using PHENIX AutoBuild (Adams et al., 2010) and COOT (Emsley et al., 2010) and refined using PHENIX Refine. The structure of HD-PTPCC-UBAP1C was determined by molecular replacement using the apo structure as the search model using PHENIX Phaser and model building and refinement in COOT and PHENIX Refine.
EPR-DEER Measurements
Proteins were purified as describe above. A 15-fold molar excess of MTSL (Toronto Research Chemicals) was mixed with the protein sample and incubated at 4°C overnight followed by SEC on a Superdex200 column (GE Healthcare) equilibrated in 20 mM HEPES, 250 mM NaCl, 5 mM EDTA (pH 7.4). Labeling was confirmed by mass spectrometry. All mutants and the WT were checked by circular dichroism to confirm the secondary structure (Figure S1). DEER samples were prepared by buffer exchange into deuterated buffer (20 mM HEPES, 250 mM NaCl, in D2O [pD 7.4]) with 30% (v/v) glycerol-d8 to a final protein concentration of 60 μM and flash frozen in 4 mm quartz tubes (Wilmad). The four-pulse DEER experiments were carried out on a pulsed ELEXSYS E580 (9 GHz) spectrometer (Bruker), cooled to 50 K with a continuous-flow helium CF935 cryostat and an isothermal calorimetry 502 temperature control system (Oxford Instruments) and analyzed with DEERAnalysis 2013.2 (Jeschke et al., 2006). Distance distribution predictions were calculated using MMM 2013.2 (Multiscale Modeling of Macromolecular systems) (Polyhach et al., 2011).
Torsion-Angle Molecular Dynamics
CNS (Crystallography & NMR System, version 1.3) (Brunger et al., 1998) was used to run torsion-angle molecular dynamics simulations (TAMDS) of HD-PTPCC models with MTSL spin-labeled side chains at selected positions. Torsional angle flexibility was limited to the MTSL side chains and the loop regions between H1 and H2 (residues 42–58) and between H2 and H3 (residues 71–73), with the remaining residues treated as rigid. DEER distance constraints were introduced between the nitrogen atoms of the MTSL groups: 42.4 ± 10 Å for C628-C425 and 61.7 ± 10 Å for C425-C697.
NMR and PRE Measurements
UBAP1C peptide was dissolved at a concentration of 1 mg/mL (∼0.5 mM) in PBS in D2O [pD 7.5]. 1H13C gradient-selected HSQC spectra were recorded at natural abundance 13C (1%) at 800 MHz, using a Bruker AVANCE III spectrometer equipped with a TCI (1H-13C-15N/2H) cryoprobe with z gradients. Pure-shift (PUSH) HSQC spectra (Paudel et al., 2013) were recorded for the uncomplexed peptide. Assignment of the H-C correlations was by HSQC-total correlation spectroscopy and nuclear Overhauser effect spectroscopy spectra, and confirmed by the behavior in the protein complexes. Complexation with HD-PTPCC was detected with the addition of 60 μM of the protein. PRE measurements were recorded by taking MTSL-labeled HD-PTPCC C697S mutant under the same conditions, recording 1H13C HSQCs, and then reducing the MTSL label (rendering it diamagnetic) with 10-fold excess of sodium ascorbate (added from 1 M stock).
Biosensor Binding Studies
Binding studies were performed at 25°C on a multiplex system ProteOn XPR36 (Bio-Rad Laboratories) in 10 mM HEPES (pH 7.4), 150 mM NaCl, 0.05% Tween 20 as running buffer, with 50–100 μg/mL of protein immobilized on an HTE chip (Bio-Rad Laboratories). Peptide solutions (50 μL) were injected at 100 μL/min. Data were analyzed with ProteOn Manager software (Bio-Rad Laboratories), using the equilibrium binding model: Response = [A] × Rmax/([A] + KD) where [A] is the analyte concentration and Rmax is the maximum response.
Yeast Two-Hybrid Analysis
HD-PTPBro1-CC, HD-PTPBro1-CC F678D, and AlixBro1-V cloned into pGBKT7 were used as described previously (Stefani et al., 2011). UBAP1 (122–308) was cloned into pGADT7. Further deletion and missense mutations in UBAP1 as indicated were generated by standard PCR-based mutagenesis. Interactions were tested using the Matchmaker Gold system (Clontech) as described previously (Stefani et al., 2011) Each triplicate experiment was repeated at least three times.
UBAP1 In Vitro Translation and Binding to HD-PTP
UBAP1-strep encoded on a pTriex5 vector (Stefani et al., 2011) was amplified using Pwo Polymerase (Roche). UBAP1 RNA was synthesized from the PCR product using T7 RNA polymerase (Promega). Protein was translated in nuclease-treated rabbit reticulocyte lysate (Promega) containing 35S-methionine (PerkinElmer), and 100 units of RNasin (Promega) for 1 hr at 30°C, followed by 10 min in the presence of 1 mM puromycin. Then 20 μL of translated protein was incubated with 5 μg His6- HD-PTPBro1-CC in 250 μL of immunoprecipitation (IP) buffer (20 mM HEPES [pH 7.4], 100 mM NaCl, 1 mM MgCl2, 1% [w/v] Triton X-100) for 2 hr at 4°C, then overnight with 3 μL of anti-His antibody (Clone HIS-1, Sigma). Samples were incubated with 20 μL of protein A-Sepharose beads (Invitrogen) for 2 hr at 4°C, then washed three times in IP buffer.
Mitochondrial Targeting Experiments
Mitochondrial targeting experiments were performed as previously described (Sato et al., 2015). HeLa cells were transiently transfected with HD-PTPBro1-CC containing an N-terminal FKBP sequence and a C-terminal myc tag (cloned into pcDNA5), Mito-FRB (a gift from Martin Lowe, Manchester, UK), and either GFP, WT UBAP1-GFP, or F268S UBAP1-GFP (in pEGFP). Mitochondrial relocation of FKBP-HD-PTPBro1-CC-myc was induced by addition of 1 μM rapamycin (Sigma) for 3 hr. Cells were then prepared for immunofluorescence microscopy as above. Mitochondrial relocation of GFP-tagged constructs was scored in three independent experiments (100 cells counted per experiment).
Cell Culture, Transfection, and siRNA Rescue Experiments
HeLa cells were grown in DMEM with 1% NEAA, 10% fetal calf serum (HyClone; Perbio) and 1% Pen-Strep Fugene 6 (Roche) was used for DNA transfections. Interferin (QBiogene) was used for siRNA, using an HD-PTP nucleotide as previously published (Doyotte et al., 2008), or a non-targeting siRNA (Dharmacon) as a control. Efficient HD-PTP knockdown was confirmed by western blotting, as previously reported (Doyotte et al., 2008). For siRNA rescue experiments, cells were knocked down for 24 hr, then transfected with WT or specified mutants of HD-PTPBro1-CC (note that the siRNA oligo targets a C-terminal sequence within HD-PTP) for 48 hr. Rescues were assessed by visual quantification of phenotypes. Cells containing clustered and strongly labeled foci of FK2 staining (previously identified as endosomal; Doyotte et al., 2008) were considered knocked down. Rescued cells displayed a WT, diffuse cytoplasmic distribution of FK2 staining. Scoring was performed for three independent experiments, with at least 100 transfected cells examined each time. Data were subjected to statistical analysis (two-way ANOVA) using Prism5 software (GraphPad). For graphical representation of rescue data, mean scores ± SD are provided for the three determinations.
Author Contributions
C.L. collected X-ray diffraction data, solved, and refined the crystal structures. D.G. cloned HD-PTP constructs, prepared protein samples, and crystallized the proteins. G.H. prepared spin-labeled proteins and collected DEER data; G.H. and A.J.F. analyzed DEER data. G.H. collected CD data and analyzed it with J.B. M.J.C. collected and analyzed NMR data. P.M. and D.G. collected SPR data and P.M. analyzed it. G.H. and J.B. performed torsion-angle molecular dynamics simulations. F.S. performed the yeast two-hybrid and co-immunoprecipitation experiments. L.W. performed the mitochondrial localization and RNAi rescue experiments. A.J.F. designed and supervised the EPR spectroscopy. P.W. supervised and analyzed all cell biology data. L.T designed and supervised the project and analyzed the structural and biophysical data. L.T and P.W. wrote the paper.
Acknowledgments
This work was support by the Medical Research Council (MR/K011049/1 to L.T. and P.W.). G.H. is funded by a BBSRC Doctoral Training Studentship. A.J.F. thanks Bruker for sponsorship. All EPR experiments were carried out at the EPSRC National EPR Research Facility & Service. We thank Diamond Light Source for access to beamlines I02 and I03 (MX8997) and their staff for assistance, the staff of the Biomolecular Analysis Facility of the Faculty of Biology Medicine and Health, and the staff at the Advanced Photon Science facilities, University of Manchester. for assistance. We thank Peristera Roboti for help with mitochondrial targeting experiments and Elaine Small for generating FKBP-HD-PTPBro1-CC-myc. We thank Melanie Vollmar, Simon Tanley and Efrain Ceh Pavia for advice.
Published: November 10, 2016
Footnotes
Supplemental Information includes five figures and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.str.2016.10.006.
Contributor Information
Philip Woodman, Email: philip.woodman@manchester.ac.uk.
Lydia Tabernero, Email: lydia.tabernero@manchester.ac.uk.
Accession Numbers
The atomic coordinates have been deposited in the PDB (PDB: 5LM1, 5LM2) and resonance assignments have been deposited in the Biological Magnetic Resonance Bank (BMRB: 26914).
Supplemental Information
References
- Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agromayor M., Soler N., Caballe A., Kueck T., Freund S.M., Allen M.D., Bycroft M., Perisic O., Ye Y., McDonald B. The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure. 2012;20:414–428. doi: 10.1016/j.str.2011.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ali N., Zhang L., Taylor S., Mironov A., Urbe S., Woodman P. Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB. Curr. Biol. 2013;23:453–461. doi: 10.1016/j.cub.2013.02.033. [DOI] [PubMed] [Google Scholar]
- Bissig C., Gruenberg J. ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol. 2014;24:19–25. doi: 10.1016/j.tcb.2013.10.009. [DOI] [PubMed] [Google Scholar]
- Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 1998;54:905–921. doi: 10.1107/s0907444998003254. [DOI] [PubMed] [Google Scholar]
- Carlton J.G., Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science. 2007;316:1908–1912. doi: 10.1126/science.1143422. [DOI] [PubMed] [Google Scholar]
- Chen D.Y., Li M.Y., Wu S.Y., Lin Y.L., Tsai S.P., Lai P.L., Lin Y.T., Kuo J.C., Meng T.C., Chen G.C. The Bro1-domain-containing protein Myopic/HDPTP coordinates with Rab4 to regulate cell adhesion and migration. J. Cell Sci. 2012;125:4841–4852. doi: 10.1242/jcs.108597. [DOI] [PubMed] [Google Scholar]
- Cheng Y., Poulos N.E., Lung M.L., Hampton G., Ou B., Lerman M.I., Stanbridge E.J. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc. Natl. Acad. Sci. USA. 1998;95:3042–3047. doi: 10.1073/pnas.95.6.3042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doyotte A., Mironov A., McKenzie E., Woodman P. The Bro1-related protein HD-PTP/PTPN23 is required for endosomal cargo sorting and multivesicular body morphogenesis. Proc. Natl. Acad. Sci. USA. 2008;105:6308–6313. doi: 10.1073/pnas.0707601105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher R.D., Chung H.Y., Zhai Q., Robinson H., Sundquist W.I., Hill C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell. 2007;128:841–852. doi: 10.1016/j.cell.2007.01.035. [DOI] [PubMed] [Google Scholar]
- Hurley J.H. ESCRTs are everywhere. EMBO J. 2015;34:2398–2407. doi: 10.15252/embj.201592484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ichioka F., Takaya E., Suzuki H., Kajigaya S., Buchman V.L., Shibata H., Maki M. HD-PTP and Alix share some membrane-traffic related proteins that interact with their Bro1 domains or proline-rich regions. Arch. Biochem. Biophys. 2007;457:142–149. doi: 10.1016/j.abb.2006.11.008. [DOI] [PubMed] [Google Scholar]
- Jeschke G., Chechik V., Ionita P., Godt A., Zimmermann H., Banham J., Timmel C.R., Hilger D., Jung H. DeerAnalysis2006-a comprehensive software package for analyzing pulsed ELDOR data. Appl. Magn. Reson. 2006;30:473–498. [Google Scholar]
- Kabsch W. XDS. Acta Crystallogr. D Biol. Crystallogr. 2010;66:125–132. doi: 10.1107/S0907444909047337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kharitidi D., Apaja P.M., Manteghi S., Suzuki K., Malitskaya E., Roldan A., Gingras M.C., Takagi J., Lukacs G.L., Pause A. Interplay of endosomal pH and ligand occupancy in integrin alpha5beta1 ubiquitination, endocytic sorting, and cell migration. Cell Rep. 2015;13:599–609. doi: 10.1016/j.celrep.2015.09.024. [DOI] [PubMed] [Google Scholar]
- Kim J., Sitaraman S., Hierro A., Beach B.M., Odorizzi G., Hurley J.H. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell. 2005;8:937–947. doi: 10.1016/j.devcel.2005.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kimura Y., Tanigawa M., Kawawaki J., Takagi K., Mizushima T., Maeda T., Tanaka K. Conserved mode of interaction between yeast Bro1 family V domains and YP(X)nL motif-containing target proteins. Eukaryot. Cell. 2015;14:976–982. doi: 10.1128/EC.00091-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kok K., Naylor S.L., Buys C.H. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 1997;71:27–92. doi: 10.1016/s0065-230x(08)60096-2. [DOI] [PubMed] [Google Scholar]
- Lee S., Joshi A., Nagashima K., Freed E.O., Hurley J.H. Structural basis for viral late-domain binding to Alix. Nat. Struct. Mol. Biol. 2007;14:194–199. doi: 10.1038/nsmb1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee J., Oh K.J., Lee D., Kim B.Y., Choi J.S., Ku B., Kim S.J. Structural study of the HD-PTP Bro1 domain in a complex with the core region of STAM2, a subunit of ESCRT-0. PLoS One. 2016;11:e0149113. doi: 10.1371/journal.pone.0149113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin G., Aranda V., Muthuswamy S.K., Tonks N.K. Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'. Genes Dev. 2011;25:1412–1425. doi: 10.1101/gad.2018911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ma H., Wardega P., Mazaud D., Klosowska-Wardega A., Jurek A., Engstrom U., Lennartsson J., Heldin C.H. Histidine-domain-containing protein tyrosine phosphatase regulates platelet-derived growth factor receptor intracellular sorting and degradation. Cell Signal. 2015;27:2209–2219. doi: 10.1016/j.cellsig.2015.07.020. [DOI] [PubMed] [Google Scholar]
- Manteghi S., Gingras M.C., Kharitidi D., Galarneau L., Marques M., Yan M., Cencic R., Robert F., Paquet M., Witcher M. Haploinsufficiency of the ESCRT component HD-PTP predisposes to Cancer. Cell Rep. 2016;15:1893–1900. doi: 10.1016/j.celrep.2016.04.076. [DOI] [PubMed] [Google Scholar]
- Mariotti M., Castiglioni S., Garcia-Manteiga J.M., Beguinot L., Maier J.A. HD-PTP inhibits endothelial migration through its interaction with Src. Int. J. Biochem. Cell Biol. 2009;41:687–693. doi: 10.1016/j.biocel.2008.08.005. [DOI] [PubMed] [Google Scholar]
- Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P., Rodesch C.K., Sundquist W.I. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 2007;26:4215–4227. doi: 10.1038/sj.emboj.7601850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parkinson M.D., Piper S.C., Bright N.A., Evans J.L., Boname J.M., Bowers K., Lehner P.J., Luzio J.P. A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. Biochem. J. 2015;471:79–88. doi: 10.1042/BJ20150336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pashkova N., Gakhar L., Winistorfer S.C., Sunshine A.B., Rich M., Dunham M.J., Yu L., Piper R.C. The yeast Alix homolog Bro1 functions as a ubiquitin receptor for protein sorting into multivesicular endosomes. Dev. Cell. 2013;25:520–533. doi: 10.1016/j.devcel.2013.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paudel L., Adams R.W., Kiraly P., Aguilar J.A., Foroozandeh M., Cliff M.J., Nilsson M., Sandor P., Waltho J.P., Morris G.A. Simultaneously enhancing spectral resolution and sensitivity in heteronuclear correlation NMR spectroscopy. Angew. Chem. 2013;52:11616–11619. doi: 10.1002/anie.201305709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pires R., Hartlieb B., Signor L., Schoehn G., Lata S., Roessle M., Moriscot C., Popov S., Hinz A., Jamin M. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure. 2009;17:843–856. doi: 10.1016/j.str.2009.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polyhach Y., Bordignon E., Jeschke G. Rotamer libraries of spin labelled cysteines for protein studies. Phys. Chem. Chem. Phys. 2011;13:2356–2366. doi: 10.1039/c0cp01865a. [DOI] [PubMed] [Google Scholar]
- Qian J., Yang J., Zhang X., Zhang B., Wang J., Zhou M., Tang K., Li W., Zeng Z., Zhao X. Isolation and characterization of a novel cDNA, UBAP1, derived from the tumor suppressor locus in human chromosome 9p21-22. J. Cancer Res. Clin. Oncol. 2001;127:613–618. doi: 10.1007/s004320100252. [DOI] [PubMed] [Google Scholar]
- Rollinson S., Rizzu P., Sikkink S., Baker M., Halliwell N., Snowden J., Traynor B.J., Ruano D., Cairns N., Rohrer J.D. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol. Aging. 2009;30:656–665. doi: 10.1016/j.neurobiolaging.2009.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato K., Roboti P., Mironov A.A., Lowe M. Coupling of vesicle tethering and Rab binding is required for in vivo functionality of the golgin GMAP-210. Mol. Biol. Cell. 2015;26:537–553. doi: 10.1091/mbc.E14-10-1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmidt M.H., Hoeller D., Yu J., Furnari F.B., Cavenee W.K., Dikic I., Bogler O. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol. Cell. Biol. 2004;24:8981–8993. doi: 10.1128/MCB.24.20.8981-8993.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sette P., Mu R., Dussupt V., Jiang J., Snyder G., Smith P., Xiao T.S., Bouamr F. The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. Structure. 2011;19:1485–1495. doi: 10.1016/j.str.2011.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stefani F., Zhang L., Taylor S., Donovan J., Rollinson S., Doyotte A., Brownhill K., Bennion J., Pickering-Brown S., Woodman P. UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. Curr. Biol. 2011;21:1245–1250. doi: 10.1016/j.cub.2011.06.028. [DOI] [PubMed] [Google Scholar]
- Sun S., Zhou X., Zhang W., Gallick G.E., Kuang J. Unravelling the pivotal role of Alix in MVB sorting and silencing of the activated EGFR. Biochem. J. 2015;466:475–487. doi: 10.1042/BJ20141156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toyooka S., Ouchida M., Jitsumori Y., Tsukuda K., Sakai A., Nakamura A., Shimizu N., Shimizu K. HD-PTP: a novel protein tyrosine phosphatase gene on human chromosome 3p21.3. Biochem. Biophys. Res. Commun. 2000;278:671–678. doi: 10.1006/bbrc.2000.3870. [DOI] [PubMed] [Google Scholar]
- von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M. The protein network of HIV budding. Cell. 2003;114:701–713. doi: 10.1016/s0092-8674(03)00714-1. [DOI] [PubMed] [Google Scholar]
- Walshaw J., Woolfson D.N. Socket: a program for identifying and analysing coiled-coil motifs within protein structures. J. Mol. Biol. 2001;307:1427–1450. doi: 10.1006/jmbi.2001.4545. [DOI] [PubMed] [Google Scholar]
- Wunderley L., Brownhill K., Stefani F., Tabernero L., Woodman P. The molecular basis for selective assembly of the UBAP1-containing endosome-specific ESCRT-I complex. J. Cell Sci. 2014;127:663–672. doi: 10.1242/jcs.140673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhai Q., Fisher R.D., Chung H.Y., Myszka D.G., Sundquist W.I., Hill C.P. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 2008;15:43–49. doi: 10.1038/nsmb1319. [DOI] [PubMed] [Google Scholar]
- Zhai Q., Landesman M.B., Robinson H., Sundquist W.I., Hill C.P. Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1. J. Virol. 2011;85:632–637. doi: 10.1128/JVI.01683-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.